Patients and the government had to foot the bill for these expensive drugs. The health of patients might also be at stake as some doctors had the incentive to prescribe excessive amounts to get more kickbacks.
GSK's practices eroded its corporate integrity and could cause irreparable damage to the company in China and elsewhere. The case is a warning to other multinationals in China that ethics matter. Increasingly attractive to foreign investors, more and more companies see China as their most important market.
These investors should learn to respect the Chinese market, at the very least by providing quality products at reasonable prices, abandoning discrimination and honoring their due social responsibilities.
For those profiteers, the market will eventually make its own choice.
GSK revamps sales reps' compensation
GSK denies it is considering leaving China
GSK revamps sales reps' compensation
Police reveals more about GSK China's violations
|
 |
 |
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 20100000002731 
